Sanofi wins enablement showdown at SCOTUS

18-05-2023

Muireann Bolger

Sanofi wins enablement showdown at SCOTUS

Case concerned the interpretation of a key requirement of the US Patent Act | Amgen’s ‘roadmap’ held to describe step-by-step its own trial-and-error method for finding functional antibodies.


Sanofi, Amgen, SCOTUS, Regeneron, Justice Gorsuch, enablement, patents, antibodies, big pharma

LSIPR